TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33835873

Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic radical prostatectomy (RALP)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Three-dimensional laparoscopic radical prostatectomy (3D LRP)
Number of subjects: 65
Study: 32439297

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon
Number of subjects: 64

Group type: COMPARATOR
Intervention: Everolimus-eluting stent
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon or Everolimus-eluting stent
Number of subjects: 64
Study: 33729724

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 703

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 703
Study: 32030694

Group type: EXPERIMENTAL
Intervention: Suprascapular and axillary nerve block (group SSAXB, n=23)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Subacromial local infiltration (group C, n=23)
Number of subjects: 46
Study: 34088249

Group type: EXPERIMENTAL
Intervention: Mental health interventions focusing on depressive symptoms and behavior change skills (e.g., self-efficacy)
Number of subjects: 424
Study: 33030228

Group type: EXPERIMENTAL
Intervention: rhFGF‐2 + DBBM (test)
Number of subjects: 38

Group type: COMPARATOR
Intervention: rhFGF‐2 (control)
Number of subjects: 38
Study: 35655058

Group type: EXPERIMENTAL
Intervention: myCompass online CBT program for 6 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: paper-based health education program
Number of subjects: 50
Study: 33486062

Group type: EXPERIMENTAL
Intervention: PROMIS Mobility score
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: PROMIS Pain Interference score
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: PROMIS Upper Extremity score
Number of subjects: 57

Group type: COMPARATOR
Intervention: Legacy metrics (KJOC, QuickDASH, Liverpool-PAQ)
Number of subjects: 57

Group type: COMPARATOR
Intervention: KJOC score
Number of subjects: 57
Study: 33389504

Group type: EXPERIMENTAL
Intervention: Portable video media (PVM) consent
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard verbal consent (SVC)
Number of subjects: 60
Study: 32927688

Group type: EXPERIMENTAL
Intervention: High temperature (HT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low temperature (LT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4 days post-anthesis (4 dpa) stage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Differentially expressed genes (DEGs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Candidate genes related to fuzz initiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Functional annotation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gene expression trends
Number of subjects: 0
Study: 36018275

Group type: EXPERIMENTAL
Intervention: VIPP‐PMH (video feedback intervention for positive parenting adapted for perinatal mental health)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 34
Study: 33217131

Group type: EXPERIMENTAL
Intervention: Robotic-guided (RG) placement of percutaneous pedicle screw instrumentation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluoroscopic-guided (FG) placement of percutaneous pedicle screw instrumentation
Number of subjects: 0
Study: 37441660

Group type: EXPERIMENTAL
Intervention: Oral glibenclamide
Number of subjects: 84

Group type: COMPARATOR
Intervention: Subcutaneous insulin
Number of subjects: 84
Study: 34454468

Group type: EXPERIMENTAL
Intervention: Parental active presence technique (PAP)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Parental passive presence technique (PPP)
Number of subjects: 150
Study: 36374913

Group type: EXPERIMENTAL
Intervention: CKD-701
Number of subjects: 312

Group type: COMPARATOR
Intervention: Reference ranibizumab
Number of subjects: 312
Study: 35299690

Group type: EXPERIMENTAL
Intervention: Mixed teaching mode
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional teaching mode
Number of subjects: 80
Study: 35132556

Group type: EXPERIMENTAL
Intervention: Naloxone co-dispensing
Number of subjects: 768

Group type: COMPARATOR
Intervention: Usual care pharmacies
Number of subjects: 768
Study: 35672861

Group type: EXPERIMENTAL
Intervention: Preoperative inspiratory muscle training using Power®Breathe KHP2, 30 breaths twice a day for at least 2 weeks before surgery (can be extended up to 6 weeks).
Number of subjects: 0

Group type: COMPARATOR
Intervention: No preoperative inspiratory muscle training (control group).
Number of subjects: 0
Study: 35993772

Group type: EXPERIMENTAL
Intervention: Home-based cryotherapy
Number of subjects: 22

Group type: COMPARATOR
Intervention: In-hospital liquid nitrogen therapy
Number of subjects: 22
Study: 33662589

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intact umbilical cord milking (I-UCM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cut umbilical cord milking (C-UCM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35235197

Group type: EXPERIMENTAL
Intervention: Biofeedback (BOF) alone
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Biofeedback + fiber laxative (psyllium)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Biofeedback + osmotic laxative (polyethylene glycol; PEG)
Number of subjects: 88

Group type: COMPARATOR
Intervention: All groups (including controls)
Number of subjects: 88
Study: 32179564

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioural therapy (iCBT) for Depression, available only in Finnish.
Number of subjects: 0
Study: 36205538

Group type: EXPERIMENTAL
Intervention: COBRA-light (prednisolone 30 mg/day tapered to 7.5 mg/day, MTX increasing to 25 mg/week)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Intensification (prednisolone 60 mg/day tapered to 7.5 mg/day, addition of SSZ (2 g/day) and HCQ (400 mg/day))
Number of subjects: 190

Group type: COMPARATOR
Intervention: Continuation (no intensification)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: MTX monotherapy increasing to 25 mg/week
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Intensification (prednisolone 30 mg/day tapered to 7.5 mg/day)
Number of subjects: 190
Study: 32001164

Group type: EXPERIMENTAL
Intervention: Radiologists' prediction of upstaging to invasive disease
Number of subjects: 150
Study: 35959775

Group type: EXPERIMENTAL
Intervention: Shenfu injection (SFI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (glucose injection)
Number of subjects: 40
Study: 34060934

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 112

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Mirror Therapy (MT)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Active MT
Number of subjects: 112
Study: 32762916

Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35259525

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 33915217

Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI) - 25 Gy in 10 fractions
Number of subjects: 84

Group type: COMPARATOR
Intervention: Standard of care (SoC)
Number of subjects: 84
Study: 33624254

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34231934

Group type: EXPERIMENTAL
Intervention: Crossover interventions
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Randomized controlled trial
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Before-after-control-impact
Number of subjects: 434

Group type: COMPARATOR
Intervention: Before-after studies
Number of subjects: 434

Group type: COMPARATOR
Intervention: Control-impact studies
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Crossover designs
Number of subjects: 434
Study: 34376213

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA)
Number of subjects: 16676

Group type: EXPERIMENTAL
Intervention: Higher-light intensity physical activity (HLPA)
Number of subjects: 16676

Group type: EXPERIMENTAL
Intervention: Physical activity guidelines (mean, 36 min/day MVPA, 79 min/day HLPA, 227 min/day LLPA, 549 min/day SB)
Number of subjects: 16676

Group type: EXPERIMENTAL
Intervention: Higher-light intensity activity (HLPA) and lower-light intensity activity (LLPA)
Number of subjects: 16676

Group type: COMPARATOR
Intervention: Sedentary behavior (SB)
Number of subjects: 16676
Study: 32029415

Group type: EXPERIMENTAL
Intervention: Video lecture and high fidelity simulation
Number of subjects: 52

Group type: COMPARATOR
Intervention: Video lecture
Number of subjects: 52
Study: 35543329

Group type: EXPERIMENTAL
Intervention: Interactive 3D software package
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard PowerPoint presentation
Number of subjects: 50
Study: 33606044

Group type: EXPERIMENTAL
Intervention: Off-clamp robotic partial nephrectomy (RPN)
Number of subjects: 1359

Group type: COMPARATOR
Intervention: On-clamp robotic partial nephrectomy (RPN)
Number of subjects: 1359

Group type: EXPERIMENTAL
Intervention: Off-clamp RPN
Number of subjects: 1359

Group type: COMPARATOR
Intervention: On-clamp RPN
Number of subjects: 1359
Study: 36047014

Group type: EXPERIMENTAL
Intervention: Superficial dry needling (DN)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham dry needling (C)
Number of subjects: 30
Study: 33503313

Group type: EXPERIMENTAL
Intervention: CT-P17
Number of subjects: 312

Group type: COMPARATOR
Intervention: US-adalimumab
Number of subjects: 312

Group type: COMPARATOR
Intervention: EU-adalimumab
Number of subjects: 312
Study: 32448810

Group type: EXPERIMENTAL
Intervention: Willingness to donate organs after death
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Registration with the Centralised Organ Donation Register (CODR)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Reasons for not registering with CODR
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Awareness of registration methods
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Social media effectiveness
Number of subjects: 1000
Study: 36170281

Group type: EXPERIMENTAL
Intervention: Minimal-flow: 0.25 l.min-1 via endotracheal tube
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Low-flow: 2 l.min-1 + continuous jaw thrust
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Medium-flow: 10 l.min-1 + continuous jaw thrust
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: High-flow: 70 l.min-1 + continuous jaw thrust
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control: 70 l.min-1 + continuous video-laryngoscopy
Number of subjects: 125
Study: 34180292

Group type: EXPERIMENTAL
Intervention: Intervention group (83 patients) had a DEXA scan and FRAX calculated.
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Intervention group (DEXA and FRAX)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (100 patients)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Intervention group (DEXA)
Number of subjects: 180
Study: 35704597

Group type: EXPERIMENTAL
Intervention: Tadalafil (20 mg, once daily)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 35151021

Group type: EXPERIMENTAL
Intervention: Common humanity-enhanced exposure (n = 32)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Exposure alone (n = 31)
Number of subjects: 63
Study: 32702759

Group type: EXPERIMENTAL
Intervention: Computer-based education (CBE)
Number of subjects: 497

Group type: COMPARATOR
Intervention: Nurse counselling
Number of subjects: 497
Study: 616858603

Group type: EXPERIMENTAL
Intervention: Self-management intervention along with conventional drug therapy
Number of subjects: 115

Group type: COMPARATOR
Intervention: Standard outpatient care and conventional drug therapy
Number of subjects: 115
Study: 34356965

Group type: EXPERIMENTAL
Intervention: Experimental group (muscle conditioning)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no physical activity)
Number of subjects: 40
Study: 35717855

Group type: EXPERIMENTAL
Intervention: Group-based Compassion-Focused Therapy (CFT)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 82
Study: 32398112

Group type: EXPERIMENTAL
Intervention: Modified Sijunzi decoction (SJZD)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Mesalazine
Number of subjects: 10
Study: 34843329

Group type: EXPERIMENTAL
Intervention: Benefit-finding therapeutic (BFT) intervention
Number of subjects: 129

Group type: COMPARATOR
Intervention: Psychoeducation (control)
Number of subjects: 129
Study: 32959585

Group type: EXPERIMENTAL
Intervention: Acupoint selection of meridian diagnosis
Number of subjects: 70

Group type: COMPARATOR
Intervention: Regular acupoint selection
Number of subjects: 70
Study: 34961383

Group type: EXPERIMENTAL
Intervention: Stigma-reducing video intervention
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Utility-enhancing video intervention
Number of subjects: 277

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 277
Study: 33826497

Group type: EXPERIMENTAL
Intervention: Dabigatran 110 mg
Number of subjects: 2725

Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg
Number of subjects: 2725

Group type: COMPARATOR
Intervention: Warfarin triple therapy
Number of subjects: 2725
Study: 36231747

Group type: EXPERIMENTAL
Intervention: Probiotic group (L. salivarius)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (usual treatment)
Number of subjects: 140
Study: 34252340

Group type: EXPERIMENTAL
Intervention: Capsiate supplementation (CTRLcap)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (CTRLpla)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Capsiate supplementation with exercise (EXcap)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo with exercise (EXpla)
Number of subjects: 13
Study: 34175315

Group type: EXPERIMENTAL
Intervention: Perhexiline
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32926504

Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitors (PPIs)
Number of subjects: 24471

Group type: EXPERIMENTAL
Intervention: High-dimensional propensity score (hd-PS) modifications
Number of subjects: 24471
Study: 35918695

Group type: EXPERIMENTAL
Intervention: MFGM-enriched formula (MF)
Number of subjects: 375

Group type: COMPARATOR
Intervention: Standard formula (SF)
Number of subjects: 375

Group type: COMPARATOR
Intervention: Breast-fed reference (BFR)
Number of subjects: 375
Study: 33207015

Group type: EXPERIMENTAL
Intervention: SQ tree SLIT-tablet (containing birch extract)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 397
Study: 32592003

Group type: EXPERIMENTAL
Intervention: Deep learning‐based computer‐aided diagnosis (CAD) system
Number of subjects: 120

Group type: COMPARATOR
Intervention: Radiologists without CAD
Number of subjects: 120
Study: 34368886

Group type: EXPERIMENTAL
Intervention: Structured education program including appearance management and mind control for 4 weeks
Number of subjects: 109
Study: 32573396

Group type: EXPERIMENTAL
Intervention: Bright light therapy (light monotherapy)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Fluoxetine (fluoxetine monotherapy)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Combination of bright light therapy and fluoxetine
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 33205201

Group type: EXPERIMENTAL
Intervention: ensoETM device (oesophageal temperature control device) maintaining luminal temperature at 4°C during RF ablation
Number of subjects: 188

Group type: COMPARATOR
Intervention: Standard practice utilizing a single-point temperature probe (control group)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: ensoETM device
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 188
Study: 32040875

Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment and Hall Technique (ART/HT)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Dental General Anaesthesia (DGA)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Crown restorations
Number of subjects: 65
Study: 35637038

Group type: EXPERIMENTAL
Intervention: Topical Cannabidiol (CBD) 6.2 mg/mL with shea butter, applied twice daily for 2 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control: Shea butter alone, applied twice daily for 2 weeks
Number of subjects: 18
Study: 33546679

Group type: EXPERIMENTAL
Intervention: Self-directed learning by video (SDL-V)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (regular duties)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups (SDL-V and Control)
Number of subjects: 22
Study: 32111479

Group type: EXPERIMENTAL
Intervention: Antioxidant formulation (n = 85) containing 500 mg of vitamin C, 400 mg of vitamin E, 0.20 mg of selenium, 1,000 mg of l-carnitine, 20 mg of zinc, 1,000 μg of folic acid, 10 mg of lycopene daily
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo (n = 86)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Antioxidant formulation
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study: 36017151

Group type: EXPERIMENTAL
Intervention: SEMS placement time = 14 days (n = 19 patients)
Number of subjects: 64

Group type: COMPARATOR
Intervention: SEMS placement time > 14 days (n = 45 patients)
Number of subjects: 64
Study: 33987881

Group type: EXPERIMENTAL
Intervention: Tonic painful pressure applied to the non-dominant leg during induction of referred pain (conditioning session)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control session with no conditioning stimulus
Number of subjects: 24
Study: 34391309

Group type: EXPERIMENTAL
Intervention: Whole-Body Vibration (WBV) therapy, 12 sessions, amplitude of 3 mm, frequency of 20 Hz, 6 days/week for 2 weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: Routine Physiotherapy (RP)
Number of subjects: 64
Study: 33320101

Group type: EXPERIMENTAL
Intervention: Wearable devices, health management platform, and social media support
Number of subjects: 60
Study: 32216204

Group type: EXPERIMENTAL
Intervention: Yishen Zhuangyang Cream (YZC)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 92
Study: 33595105

Group type: EXPERIMENTAL
Intervention: 3D CNN model for pancreas segmentation at full dose CT
Number of subjects: 1917

Group type: EXPERIMENTAL
Intervention: 3D CNN model for pancreas segmentation at reduced dose CT
Number of subjects: 1917

Group type: COMPARATOR
Intervention: 3D CNN model vs R1 at full dose CT
Number of subjects: 1917

Group type: COMPARATOR
Intervention: 3D CNN model vs R2 at full dose CT
Number of subjects: 1917

Group type: COMPARATOR
Intervention: 3D CNN model vs R1 at reduced dose CT
Number of subjects: 1917

Group type: COMPARATOR
Intervention: 3D CNN model vs R2 at reduced dose CT
Number of subjects: 1917

Group type: EXPERIMENTAL
Intervention: 3D CNN model on NIH-PCT dataset
Number of subjects: 1917
Study: 32322324

Group type: EXPERIMENTAL
Intervention: R‐EBUS‐guided transbronchial lung biopsy (TBLB)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Transbronchial lung biopsy (TBLB)
Number of subjects: 121
Study: 36370703

Group type: EXPERIMENTAL
Intervention: Brain Endurance Training (BET)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (listening to neutral sounds)
Number of subjects: 22
Study: 34373322

Group type: EXPERIMENTAL
Intervention: 0.45% sodium chloride fluids
Number of subjects: 1251

Group type: COMPARATOR
Intervention: 0.9% sodium chloride fluids
Number of subjects: 1251

Group type: EXPERIMENTAL
Intervention: Higher rates of fluid infusion
Number of subjects: 1251
Study: 36288782

Group type: EXPERIMENTAL
Intervention: Dyson high‐efficiency particulate air air purifier
Number of subjects: 50

Group type: COMPARATOR
Intervention: Dummy filters (placebo)
Number of subjects: 50
Study: 34413362

Group type: EXPERIMENTAL
Intervention: Bifocal glasses (add +2.5 Dioptres; n=50)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Unifocal glasses (n=52)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Bifocal glasses (n=50)
Number of subjects: 102
Study: 32306925

Group type: EXPERIMENTAL
Intervention: Return-to-work (RTW) intervention provided by RTW experts in intervention wards.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) in control wards.
Number of subjects: 200
Study: 33320223

Group type: EXPERIMENTAL
Intervention: Aflibercept (100 participants)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Vitrectomy with panretinal photocoagulation (105 participants)
Number of subjects: 205
Study: 36381249

Group type: EXPERIMENTAL
Intervention: Denosumab biosimilar (LY06006) 60 mg subcutaneously every 6 months for 1 year
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Denosumab biosimilar (LY06006)
Number of subjects: 448

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 448
Study: 34397702

Group type: EXPERIMENTAL
Intervention: Growtropin‐II (recombinant human GH)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Genotropin
Number of subjects: 75

Group type: COMPARATOR
Intervention: Non-treatment group
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Growtropin‐II
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Growtropin‐II and Genotropin
Number of subjects: 75
Study: 32957414

Group type: EXPERIMENTAL
Intervention: Hachimijiogan (HJG)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no additional HJG)
Number of subjects: 86
Study: 34852379

Group type: EXPERIMENTAL
Intervention: 100 mg daily aspirin
Number of subjects: 13547

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13547
Study: 33573699

Group type: EXPERIMENTAL
Intervention: High-dose intravenous vitamin C (HDIVC) 6 g daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lopinavir/ritonavir and hydroxychloroquine (Control)
Number of subjects: 60
Study: 33753853

Group type: EXPERIMENTAL
Intervention: Active transcranial direct-current stimulation (a‐tDCS) at 2 mA for 20 min
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham transcranial direct-current stimulation (s‐tDCS)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Active transcranial direct-current stimulation (a‐tDCS)
Number of subjects: 100
Study: 32201622

Group type: EXPERIMENTAL
Intervention: Women for Women International (WfWI) economic and social empowerment programme
Number of subjects: 1461
Study: 35140880

Group type: EXPERIMENTAL
Intervention: Mindfulness-based Tai Chi Chuan (MTCC)
Number of subjects: 59